Request Demo
Last update 17 May 2025
FCN-647
Last update 17 May 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms FCN 647 |
Target |
Action inhibitors |
Mechanism BTK inhibitors(Tyrosine-protein kinase BTK inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with FCN-647CTR20210068
一项多中心、开放、单臂I 期剂量探索研究，评价FCN-647 在复发或难治性B 淋巴细胞恶性肿瘤患者中的安全性、耐受性、药代动力学特征和初步抗肿瘤活性
[Translation] A multicenter, open-label, single-arm, Phase I dose-finding study to evaluate the safety, tolerability, pharmacokinetic profile, and preliminary antitumor activity of FCN-647 in patients with relapsed or refractory B-lymphocyte malignancies
100 Clinical Results associated with FCN-647
Login to view more data
100 Translational Medicine associated with FCN-647
Login to view more data
100 Patents (Medical) associated with FCN-647
Login to view more data
100 Deals associated with FCN-647
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| B-Cell Malignant Neoplasm | Phase 1 | China | 31 Mar 2021 | |
| Chronic Lymphocytic Leukemia | IND Approval | China | 29 Feb 2024 | |
| Small Lymphocytic Lymphoma | IND Approval | China | 29 Feb 2024 | |
| Lymphoma | IND Application | China | 19 Feb 2024 | |
| B-Cell Lymphoma | IND Application | China | 05 Nov 2019 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free